186 related articles for article (PubMed ID: 24400795)
1. Probiotic antigens stimulate hepatic natural killer T cells.
Liang S; Webb T; Li Z
Immunology; 2014 Feb; 141(2):203-10. PubMed ID: 24400795
[TBL] [Abstract][Full Text] [Related]
2. Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells.
Ma X; Hua J; Li Z
J Hepatol; 2008 Nov; 49(5):821-30. PubMed ID: 18674841
[TBL] [Abstract][Full Text] [Related]
3. Pro-inflammatory activated Kupffer cells by lipids induce hepatic NKT cells deficiency through activation-induced cell death.
Tang T; Sui Y; Lian M; Li Z; Hua J
PLoS One; 2013; 8(12):e81949. PubMed ID: 24312613
[TBL] [Abstract][Full Text] [Related]
4. Tim-3/galectin-9 regulate the homeostasis of hepatic NKT cells in a murine model of nonalcoholic fatty liver disease.
Tang ZH; Liang S; Potter J; Jiang X; Mao HQ; Li Z
J Immunol; 2013 Feb; 190(4):1788-96. PubMed ID: 23296703
[TBL] [Abstract][Full Text] [Related]
5. A comparative study on roles of natural killer T cells in two diet-induced non-alcoholic steatohepatitis-related fibrosis in mice.
Zheng S; Yang W; Yao D; Tang S; Hou J; Chang X
Ann Med; 2022 Dec; 54(1):2233-2245. PubMed ID: 35950602
[TBL] [Abstract][Full Text] [Related]
6. Activation of hepatic iNKT2 cells by α-GalCer ameliorates hepatic steatosis induced by high-fat diet in C57BL/6J mice.
Chen D; Gao X; Wang J; Zhao H; Liu H; Chen S; Zhang J; Meng M
Int Immunopharmacol; 2019 Sep; 74():105727. PubMed ID: 31284229
[TBL] [Abstract][Full Text] [Related]
7. NKT cell modulates NAFLD potentiation of metabolic oxidative stress-induced mesangial cell activation and proximal tubular toxicity.
Alhasson F; Dattaroy D; Das S; Chandrashekaran V; Seth RK; Schnellmann RG; Chatterjee S
Am J Physiol Renal Physiol; 2016 Jan; 310(1):F85-F101. PubMed ID: 26447219
[TBL] [Abstract][Full Text] [Related]
8. Genetic inactivation of the LIGHT (TNFSF14) cytokine in mice restores glucose homeostasis and diminishes hepatic steatosis.
Herrero-Cervera A; Vinué Á; Burks DJ; González-Navarro H
Diabetologia; 2019 Nov; 62(11):2143-2157. PubMed ID: 31388695
[TBL] [Abstract][Full Text] [Related]
9. Preactivation of NKT cells with alpha-GalCer protects against hepatic ischemia-reperfusion injury in mouse by a mechanism involving IL-13 and adenosine A2A receptor.
Cao Z; Yuan Y; Jeyabalan G; Du Q; Tsung A; Geller DA; Billiar TR
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G249-58. PubMed ID: 19556359
[TBL] [Abstract][Full Text] [Related]
10. Kupffer cell and interleukin-12-dependent loss of natural killer T cells in hepatosteatosis.
Kremer M; Thomas E; Milton RJ; Perry AW; van Rooijen N; Wheeler MD; Zacks S; Fried M; Rippe RA; Hines IN
Hepatology; 2010 Jan; 51(1):130-41. PubMed ID: 20034047
[TBL] [Abstract][Full Text] [Related]
11. Intrahepatic natural killer T cell populations are increased in human hepatic steatosis.
Adler M; Taylor S; Okebugwu K; Yee H; Fielding C; Fielding G; Poles M
World J Gastroenterol; 2011 Apr; 17(13):1725-31. PubMed ID: 21483633
[TBL] [Abstract][Full Text] [Related]
12. NF-κB1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses.
Locatelli I; Sutti S; Vacchiano M; Bozzola C; Albano E
Clin Sci (Lond); 2013 Feb; 124(4):279-87. PubMed ID: 22970906
[TBL] [Abstract][Full Text] [Related]
13. Combination of Probiotics and
Wang W; Xu AL; Li ZC; Li Y; Xu SF; Sang HC; Zhi F
Diabetes Metab J; 2020 Apr; 44(2):336-348. PubMed ID: 31950772
[TBL] [Abstract][Full Text] [Related]
14. Dietary fatty acids modulate antigen presentation to hepatic NKT cells in nonalcoholic fatty liver disease.
Hua J; Ma X; Webb T; Potter JJ; Oelke M; Li Z
J Lipid Res; 2010 Jul; 51(7):1696-703. PubMed ID: 20185414
[TBL] [Abstract][Full Text] [Related]
15. Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease.
Syn WK; Oo YH; Pereira TA; Karaca GF; Jung Y; Omenetti A; Witek RP; Choi SS; Guy CD; Fearing CM; Teaberry V; Pereira FE; Adams DH; Diehl AM
Hepatology; 2010 Jun; 51(6):1998-2007. PubMed ID: 20512988
[TBL] [Abstract][Full Text] [Related]
16. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease.
Li Z; Yang S; Lin H; Huang J; Watkins PA; Moser AB; Desimone C; Song XY; Diehl AM
Hepatology; 2003 Feb; 37(2):343-50. PubMed ID: 12540784
[TBL] [Abstract][Full Text] [Related]
17. Probiotics alleviate adipose inflammation in high-fat diet-induced obesity by restoring adipose invariant natural killer T cells.
Wang X; Ba T; Cheng Y; Zhang P; Chang X
Nutrition; 2021 Sep; 89():111285. PubMed ID: 34116395
[TBL] [Abstract][Full Text] [Related]
18. CXCR6 deficiency ameliorates ischemia-reperfusion injury by reducing the recruitment and cytokine production of hepatic NKT cells in a mouse model of non-alcoholic fatty liver disease.
Zhu H; Zhang Q; Chen G
Int Immunopharmacol; 2019 Jul; 72():224-234. PubMed ID: 31002999
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease.
Tang Y; Bian Z; Zhao L; Liu Y; Liang S; Wang Q; Han X; Peng Y; Chen X; Shen L; Qiu D; Li Z; Ma X
Clin Exp Immunol; 2011 Nov; 166(2):281-90. PubMed ID: 21985374
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats.
Li S; Liao X; Meng F; Wang Y; Sun Z; Guo F; Li X; Meng M; Li Y; Sun C
PLoS One; 2014; 9(1):e86724. PubMed ID: 24489777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
